BioAtla, Inc.
10-K
March 31, 2026
Key Highlights
- Exploring strategic alternatives including a potential company or asset sale
- Proprietary 'Conditionally Active Biologics' (CABs) technology platform
- Aggressive cost-cutting measures including a 40% workforce reduction
Read Analysis
🤖 AI Generated